View in EDS PDF Full Text

miR-125b 通过靶向 BCL-2 逆转宫颈癌 SiHa 细胞顺铂耐药的机制.

Saved in:
Bibliographic Details
Title: miR-125b 通过靶向 BCL-2 逆转宫颈癌 SiHa 细胞顺铂耐药的机制.
Alternate Title: Mechanism of miR-125b Reversing Cisplatin Resistance in Cervical Cancer SiHa Cells by Targeting BCL-2.
Authors: 王书君1, 经莉1 Ji771821@163.com
Source: Journal of International Obstetrics & Gynecology. Aug2026, Vol. 53 Issue 4, p390-396. 7p.
Database: Academic Search Ultimate
Description
ISSN:16741870
DOI:10.12280/gjfckx.20260116